1. Home
  2. LVLU vs TXMD Comparison

LVLU vs TXMD Comparison

Compare LVLU & TXMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lulu's Fashion Lounge Holdings Inc.

LVLU

Lulu's Fashion Lounge Holdings Inc.

SELL

Current Price

$7.21

Market Cap

34.6M

ML Signal

SELL

Logo TherapeuticsMD Inc.

TXMD

TherapeuticsMD Inc.

SELL

Current Price

$1.84

Market Cap

21.4M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
LVLU
TXMD
Founded
1996
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
34.6M
21.4M
IPO Year
2021
2012

Fundamental Metrics

Financial Performance
Metric
LVLU
TXMD
Price
$7.21
$1.84
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
8.7K
★ 18.6K
Earning Date
11-12-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 73.68
EPS
N/A
★ 0.06
Revenue
★ $282,284,000.00
$1,761,000.00
Revenue This Year
$3.58
$207.74
Revenue Next Year
$357.61
$2.15
P/E Ratio
★ N/A
$91.50
Revenue Growth
N/A
★ 35.25
52 Week Low
$4.89
$1.43
52 Week High
$32.32
$2.95

Technical Indicators

Market Signals
Indicator
LVLU
TXMD
Relative Strength Index (RSI) 27.96 50.09
Support Level N/A $1.77
Resistance Level $13.13 $2.16
Average True Range (ATR) 1.03 0.08
MACD -0.30 0.02
Stochastic Oscillator 10.75 82.14

Price Performance

Historical Comparison
LVLU
TXMD

About LVLU Lulu's Fashion Lounge Holdings Inc.

Lulus Fashion Lounge Holdings Inc is a fashion brand serving Millennial and Gen Z women. Its products include Fall Dresses, Winter Dresses, Sweater Dresses, Short Dresses, Casual Dresses, Wedding Dresses, and Denims, among others. The company generates the majority of its revenue from customers based in the United States.

About TXMD TherapeuticsMD Inc.

TherapeuticsMD Inc is a pharmaceutical royalty company that owns and manages intellectual property, including trademarks and product rights, which are licensed to third-party pharmaceutical companies. The company generates revenue mainly through royalties and milestone payments from licensed products, including IMVEXXY, BIJUVA, and ANNOVERA, and does not directly manufacture or market pharmaceutical products.

Share on Social Networks: